BioCentury | Jun 9, 2020
Product Development

Lilly’s Junshi-partnered program becomes China’s first COVID-19 mAb in clinic

...Editor Veklury, remdesivir (GS-5734) Junshi-COVID-19-unknown AZD1222, ChAdOx1 nCov-19 (ChAdOx1) Gilead Sciences Inc. Shanghai Junshi Biosciences Co. Eli Lilly and Co. Oxford BioMedica plc Morningside Venture Partners AstraZeneca...
Items per page:
1 - 1 of 1
BioCentury | Jun 9, 2020
Product Development

Lilly’s Junshi-partnered program becomes China’s first COVID-19 mAb in clinic

...Editor Veklury, remdesivir (GS-5734) Junshi-COVID-19-unknown AZD1222, ChAdOx1 nCov-19 (ChAdOx1) Gilead Sciences Inc. Shanghai Junshi Biosciences Co. Eli Lilly and Co. Oxford BioMedica plc Morningside Venture Partners AstraZeneca...
Items per page:
1 - 1 of 1